Phase I trial of intravenous IL-4 Pseudomonos exotoxin protein (NBI-3001) in patients with advanced solid tumors that express the IL-4 receptor

Linda Garland, Barbara Gitlitz, Scot Ebbinghaus, Henry Pan, Hans De Haan, Raj K. Puri, Daniel Von Hoff, Robert Figlin

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I trial of intravenous IL-4 Pseudomonos exotoxin protein (NBI-3001) in patients with advanced solid tumors that express the IL-4 receptor'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science